( October 24, 2025, 8:18 AM EDT) -- WASHINGTON, D.C. — The U.S. Judicial Panel on Multidistrict Litigation will hear arguments in December on whether cases alleging that the use of glucagon-like peptide-I receptor agonist (GLP-1 RA) medications caused permanent vision loss should be consolidated with the cases in the MDL alleging gastrointestinal injuries....